CHAIR: Ephrat Levy-Lahad, MD, Shaare Zedek Medical Center, Jerusalem, Israel
Moderated one-hour interactive discussions with the aim of fostering bilateral knowledge transfer. Choice of the following 2 SIGs.
In this session, attendees will join the presenters in exploring clinico-pathological aspects of a set of well-known and less well-known breast and ovarian cancer susceptibility genes. Dr. Tischkowitz will focus on CDH1, Dr. Hoogerbrugge on PTEN and NTHL1 and Dr. Weitzel will discuss TP53. Attendees will be encouraged to send in specific cases in advance for discussion at the SIG.
In this interactive case-based session, Dr. Hurley will explore advance concepts in genetic counselling and will show how counsellors can help clients cope with the challenges associated with discovering their genetic status.
CHAIR: Mark Robson, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA